Pegasus Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,018
Closed -$578K 78
2022
Q1
$578K Sell
8,018
-562
-7% -$40.5K 0.25% 65
2021
Q4
$788K Sell
8,580
-1,759
-17% -$210K 0.32% 63
2021
Q3
$1.31M Buy
10,339
+1,121
+12% +$163K 0.6% 48
2021
Q2
$1.53M Buy
9,218
+491
+6% +$79.6K 0.72% 46
2021
Q1
$1.59M Buy
8,727
+639
+8% +$148K 0.8% 44
2020
Q4
$1.62M Buy
+8,088
New +$1.64M 0.89% 39

Other funds holding TDOC

Pegasus Asset Management's TDOC Position: Q2 2022 in Review

Pegasus Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 8,018 shares — an estimated $578K sold.

Pegasus Asset Management first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $1.62M in Q4 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Pegasus Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Pegasus Asset Management sold 8,018 Teladoc Health shares in Q2 2022, an estimated $578K.
  • Pegasus Asset Management first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • Pegasus Asset Management's Teladoc Health position peaked at $1.62M in Q4 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Pegasus Asset Management's 13F filing for Q2 2022, filed 1 Aug 2022.